Biology and targetability of the extended spectrum of PIK3CA mutations (PIK3CAm) detected in breast carcinoma.
Hope S RugoKira RaskinaAlexa B SchrockRussell W MadisonRyon P GrafEthan S SokolSmruthy S SivakumarJessica K LeeVirginia A FisherGeoffrey R OxnardHanna TukachinskyPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
CGP detects diverse PIK3CAm in a greater number of patients with ABC than PCR hotspot testing; 20% of patients with PIK3CAm do not have SOLAR1m. These patients may derive benefit from alpelisib.